Abstract
Introduction
Drug-coated balloons (DCB) haven proven ef--gioplasty of de novo lesions in small vessels [1, 2] . Most DCBs are coated with the mitotic inhibitor -paclitaxel. The SeQuent Please™ DCB releases ≥ 30 s [2, 3] . An a priori combination therapy of bare metal stent (BMS) implantation post-dilated with a paclitaxel-coated balloon (PCB) seems worth investigating, since it combines the mechanical forces of a stent with an antiproliferative drug applied in a "single-shot" fashion over a large contact surface to the vessel wall [4] .
Previous studies have shown inconsistent results regarding the antiproliferative strength of such an adjunctive procedure [5] [6] [7] [8] [9] [10] . Yet, no data about the time course of arterial vessel response and stent coverage after such a procedure is available. Optical coherence tomography (OCT) allows precise vessel and stent evaluation in vivo. However, a three-dimensional (3D) illustration of investigated vessel segments that enables simple recognition of analyzed OCT parameters at a glance is needed.
We aimed to evaluate vessel response at 2 and 6 months after an a priori therapy with a BMS post-dilated with a PCB regarding incomplete stent apposition (ISA) and coverage using OCT. A novel 3D analysis of stented vessel segments and its comprehensive illustration as spread out charts ("carpet-views") was implemented.
Methods

Study design
disease and indication for elective percutaneous coronary intervention (PCI) of a native coronary lesion were included into the OCTOPUS trial. Patients were randomly assigned to receive treatment either with the Xience V™ (Abbott Vascular, Illinois, USA) drug-eluting stent (DES) or a comwith the PCB SeQuent Please™ (both BBraun Melsungen, Germany) [9, 11] . This sub-study of the aforementioned trial focuses only at the treatment arm BMS + PCB at 2-and 6-month OCT follow-up (Fig. 1) . Due to ethical reasons, only patients with an indication for staged PCI received serial OCT investigation at both follow-up intervals. The study was conducted at the University Hospital of Jena according to the ethical principles of the Declaration of Helsinki.
Study devices and interventions
The detailed procedural protocol has been published. Only 2.5 mm or 3.0 mm stent diameters with two stent lengths (16 mm and 25 mm) were allowed. Lesion preparation with pre-dilation or direct stenting was conducted on the operator's discretion. To provide a safety margin at the stent edges, all BMS were post-dilated with a longer PCB (20 mm or 30 mm). Afterwards no further intervention of the study lesion was undertaken. 
Angiographic analysis
Quantitative coronary angiography (QCA) was performed according to the 15-coronary tree segment system (CAAS version 5. 
Optical coherence tomography
Time-domain OCT imaging (M2 CV system, LightLab Imaging Inc., Westford, MA, USA) of the study stent was performed and images were analyzed in 1 mm steps. The detailed OCT protocol has been published [9, 11] .
OCT parameters
Struts were counted per cross-section and classified as either covered or uncovered, and regarding apposition as mal-apposed or apposed/ /embedded or laying over a side branch ostium. ISA from the adluminal strut side to the luminal vessel wall. Among others, the following parameters were calculated: (1) proliferation volume/cm stent length; (2) peak and median relative proliferation area = (1 -[minimal lumen area/stent area within the same frame]) × 100; (3) remodeling volume = integral of (lumen area -stent area + ISA area) over stent length; (4) total and relative ISA volumes, and (5) total and relative ISA surface areas. Volumetric parameters were computed through the integral of area measurements over stent length.
Statistical analysis
Statistical analysis was performed using SPSS for Windows (version 21.0.0.0, SPSS, Chicago, Ill). Continuous variables are expressed as mean ± standard deviation and were tested with the oneway analysis of variance in case of normal distributed variables. Categorical variables are presented as percentages and analyzed with the Pearson c 2 test. Repeated measurements of patients with both, 2-and 6-month follow-up, were analyzed with the non-parametric paired Wilcoxon signedp-values < 0.05.
Results
Study population
Altogether 33 lesions were treated. Six-month follow-up with QCA and OCT analyses was available in 24 patients. Sixteen patients returning to the clinic for staged PCI within 2 months after index PCI received OCT imaging of the study vessel. Among them, 7 patients also returned for 6-month invasive follow-up (Fig. 1) . Tables 1 and 2 show clinical and procedural characteristics. Predilation was conducted with a mean of 1.69 ± 2.2 in the 2-month follow-up group and 0.96 ± 1.3 times Data are expressed as mean ± standard deviation or number (%) of subjects; # 7 patients with 8-week and 6-month follow-up belong to both groups in the 6-month follow-up group (NS). The relation -sel diameters (RVD: given as mean values of two diameter measurements per proximal and distal reference site) yields an overstretch ratio (SD/ /RVD OCT ) of 106.9 ± 17.8% ( Table 2) .
Comparison of invasive follow-up at 2 and 6 months
ISA at 2 months compared to 6 month-follow-up (11.4 ± 11.8% vs. 2.2 ± 5.0%; p = 0.001) ( Table 3 , Fig. 2 ), which was depicted with various OCT parameters (number of ISA regions, ISA volumes, ISA depth and ISA surface areas) ( Table 3 ) and went along with significantly more uncovered struts compared to 6-month follow-up (14.5 ± 14.8% vs. 2.0 ± 5.3%, p = 0.001) ( Table 3) . We noted positive vessel remodeling with larger remodeling volumes after 2 months compared to 6 months (0.26 ± 0.35 mm 3 /cm vs. 0.11 ± 0.14 mm 3 /cm, p = 0.071). At 6 months the suspected positive vessel remodeling with severe ISA was largely reversible ( 
Serial analysis of the same stent at 2-and 6-month follow-up
We found significantly greater remodeling volumes, larger ISA depths, more ISA regions and more uncovered struts at the early 2-month 7 lesions (7 patients) were included in both groups due to sequential follow-up and 1 patient was included with 2 study lesions www.cardiologyjournal.org follow-up and reversible effects after 6 months (Table 4) corresponding to the shown interindividual analysis above (Figs. 3, 4) .
OCT "carpet view"
Of each investigated stented vessel segment, a 3D spread out chart was created. The 3D illustrates (1) stent circumference (X-axis and blue line), (2) analyzed stent or vessel length and, (3) degree of stent incorporation in the vessel wall (neointimal thickness of stent struts, negative values), or distance of struts with ISA from luminal border (positive values) (Figs. 3, 4) . Stent struts are displayed as colored dots depending on their quality of coverage and apposition.
Discussion
Data regarding an a priori strategy of BMS + PCB in de novo coronary artery stenoses are still of the PERfECT trial, a randomized study of BMS/ /PCB vs. BMS in de novo stenoses showed superiority for an adjunctive delivery of paclitaxel by a coated balloon for clinical endpoints [10] . O the contrary, another recently published randomized study found an increased stent thrombosis rate for the concept of BMS + PCB compared to the investigating the course of vessel healing after a BMS + PCB approach using QCA and OCT. *1 patient had only an angiographic follow-up without OCT imaging; # 7 lesions (7 patients) were included in both groups due to sequential follow-up and 1 patient was included with 2 study lesions; ISA -incomplete stent apposition; MLD -minimal lumen diameter; OCT -optical coherence tomography; QCA -quantitative coronary angiography; RLD -reference lumen diameter Figure 2 . Remodeling volume, percent struts with incomplete stent apposition (ISA) and percent uncovered struts (means and standard errors of the mean) comparing study stents after 2 and 6 months. A. Entire study population; B. Serial comparison in 7 patients; *p < 0.05; **p = 0.001. Table 4 . Serial analysis of the same study stent at 2-and 6-month follow-up, lesion-based analysis [mean ± SD (median)].
2-month follow-up (n = 7)
6-month follow-up (n = 7) P 
Strut coverage and neointimal proliferation
We found a high percentage of uncovered struts (14.5 ± 14.8%) 2 months after a combination therapy of BMS + PCB. Histological studies showed an increased risk of stent thrombosis if ≥ 30% of struts are uncovered [14] . With respect to the standard deviation of our results, duration of dual antiplatelet therapy below 6 should be avoided. Stent coverage after a BMS + PCB approach is similar to those of paclitaxel-and sirolimus-eluting stents after 6 months (~5-8% uncovered struts) [6, 9, 15, 16] . However, newer generation everolimus-and zotarolimus-eluting stents seem to have a better (0.1 ± 0.4% after 6 months) and faster stent endothelialization (4.7 ± 5.7-6.2 ± 6.9% after 3 months) [15, 17] .
Incomplete stent apposition and positive vessel remodeling
At early 2-month follow-up we found severe -pansion. Since we did not perform OCT at baseline, positive vessel remodeling cannot be completely proven. However, chosen stent diameters were appropriate according to RVDs and stents were well expanded. There was no clustering of areas with ISA, neither at the stent edges nor elsewhere. ISA were distributed over the entire stent length involving only small sectors and not more than a quadrant per cross-section.
Histological studies showed that paclitaxel leads to vessel wall dilation due to a decrease in media wall thickness, focal wall hemorrhage and cell necrosis [18, 19] . Vascular enlargement after a "paclitaxel-coated balloon only" approach for de novo coronary stenosis has been demonstrated [20, 21] . Thus, our results give the pathophysiological clue (focal positive vessel remodeling) for the increased stent thrombosis rates after BMS/PCB as previously published [13] . Furthermore, the reversibility of the observed positive remodeling after a BMS/PCB procedure. It has been shown that there is a delayed arterial healing for ISA depths ≥ of paclitaxel via a polymer-stent-matrix seems to induce different or rather alleviated focal vessel effects [10] . PCB induce a much higher paclitaxel 24], and dose-dependent positive vessel remodeling with reversible effects at long-term follow-up have been observed [25] [26] [27] [28] . Paclitaxel induces -pared to mTOR inhibitors. Histological analysis of a BMS + PCB combination in a swine model also revealed delayed stent endothelialization and OCT "carpet view" manual input of stent struts and vessel dimensions which enables a real 3D picture of stented vessel segments as spread out was implemented ("carpet view" , Figs. 3, 4) . This novel comprehensive illustration of OCT-derived parameters enables recognition of strut coverage including neointimal thickness, distribution of ISA clusters and assessment of lumen and stent perimeters at a glance.
Clinical implications
We see no added clinical value for a primary strategy using BMS + PCB compared to modern DES given the large amounts of ISA after 2 months, lack of better stent coverage and the lower anti-proliferative effects [7] [8] [9] 31] . In case of bailout situations during a planned "PCB only" intervention with the need for subsequent stent implantation, short duration of dual antiplatelet therapy might be harmful.
Limitations of the study
Our patient cohort is relatively small and the study was not aligned for clinical endpoints. Calculated remodeling volumes are only surrogate -up -vessel volume post-PCI) since OCT was not performed at baseline. Due to clustered data, the statistical analysis should be considered an approximation. We decided to simplify the analysis and its methodological description, since only secondary endpoints of the study were affected by this potential limitation. A true serial study was only performed in 7 patients, which is methodologically an insolvable problem, because the 2-month/6-month groups can be statistically analyzed neither as independent nor as paired samples.
Conclusions
Bare metal stenting in combination with simultaneous application of paclitaxel by a balloon shows transient severe ISA, most likely due to focal to be, at least temporarily, unfavorable in combination with a stent cage. The novel 3D "carpet-view" apposition and coverage, neointima proliferation, distribution of clusters and assessment of lumen and stent perimeters at a glance. 
